about
Vascular adhesion protein-1 regulates leukocyte transmigration rate in the retina during diabetesPrevalence of diabetic retinopathy and cataract in adult patients with type 1 and type 2 diabetes in Russia.Automated retinal imaging and trend analysis - a tool for health monitoring.Alteration of growth factors and neuronal death in diabetic retinopathy: what we have learned so far.Elevation of serum apelin-13 associated with proliferative diabetic retinopathy in type 2 diabetic patients.The role of apelin in the retina of diabetic rats.Comprehensive Review of the Effects of Diabetes on Ocular Health.Alterations of epithelial stem cell marker patterns in human diabetic corneas and effects of c-met gene therapyIGF-1 signaling via the PI3K/Akt pathway confers neuroprotection in human retinal pigment epithelial cells exposed to sodium nitroprusside insult.Elevated LRP6 levels correlate with vascular endothelial growth factor in the vitreous of proliferative diabetic retinopathy.Persistence of reduced expression of putative stem cell markers and slow wound healing in cultured diabetic limbal epithelial cells.Diabetes and the heart: could the diabetic myocardium be protected by preconditioning?Enhanced wound healing, kinase and stem cell marker expression in diabetic organ-cultured human corneas upon MMP-10 and cathepsin F gene silencing.Animal Models of Diabetic Retinopathy.Diabetic complications in the cornea.Gestational diabetes mellitus is a significant risk factor for long-term ophthalmic morbidity.Fasting Plasma Sugar: A Predictor of Accommodative Function in Diabetes.Increased Serum Chemerin Levels in Diabetic Retinopathy of Type 2 Diabetic Patients.
P2860
Q28576300-0E89E4E6-ED25-4BDA-ABE5-8A3056E436B9Q33508839-6B522D8E-066B-4415-825F-DD14451258BCQ33739767-A4D85244-BEC1-4907-AB34-0D80520D8FDAQ34545203-CFEC2B82-921B-44B7-AED5-3D674D163B42Q34735799-DF9188C3-44A5-451C-ADF7-2634EDF7BD05Q34854449-0D9009B7-3C4D-489B-9A52-4F32587700E9Q35099333-7EB91342-EB6E-4B0C-8460-A44E67968D0DQ35175327-4B651896-62D0-418A-AB2E-1F74236AEDC4Q35360187-D4A89433-341E-4B53-B2A5-4B392B8F676AQ35717941-DB85D19B-98F2-4843-BD85-4C1FB337D7E0Q36440534-E9E9C46B-855E-42B6-9F15-D2FEE2CC03CFQ36981806-C1EB201C-E88C-4083-A1EB-90E90298BC91Q37401560-C99EFAD2-654B-4768-8B3F-C9047FC559B0Q38401907-72A1F746-BBC1-44F3-850D-1CD1802639AEQ39238815-C154B2CF-EC82-4E15-9E83-C07E1405E398Q40252382-4D4C6E9F-0863-4721-AC7E-F1BDE8CE1EE0Q41419148-A7F8327E-9471-4F8F-818E-D658F95BE9F0Q53552556-81978922-4E53-4EDF-98AC-2775714B8A9B
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
An overview of the eye in diabetes.
@en
An overview of the eye in diabetes.
@nl
type
label
An overview of the eye in diabetes.
@en
An overview of the eye in diabetes.
@nl
prefLabel
An overview of the eye in diabetes.
@en
An overview of the eye in diabetes.
@nl
P2860
P356
P1476
An overview of the eye in diabetes.
@en
P2093
Stephen A Vernon
P2860
P304
P356
10.1258/JRSM.96.6.266
P407
P577
2003-06-01T00:00:00Z